| First Choice Health Centers, Inc. | |
|
809 Main Street East Hartford CT 06108 | |
| (860) 610-6131 | |
| (860) 290-4142 |
| Full Name | First Choice Health Centers, Inc. |
|---|---|
| Speciality | Clinic/Center |
| Location | 809 Main Street, East Hartford, Connecticut |
| Authorized Official Name and Position | Eugene A Market (CHIEF EXECUTIVE OFFICER) |
| Authorized Official Contact | 8606106131 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| First Choice Health Centers, Inc. 94 Connecticut Blvd East Hartford CT 06108-3013 Ph: (860) 528-1359 | First Choice Health Centers, Inc. 809 Main Street East Hartford CT 06108 Ph: (860) 610-6131 |
| NPI Number | 1225559826 |
|---|---|
| Provider Enumeration Date | 07/05/2017 |
| Last Update Date | 07/05/2017 |
| Medicare PECOS PAC ID | 2769417609 |
|---|---|
| Medicare Enrollment ID | O20170907000210 |
News Archive
The National Council on Disability (NCD) will release a report on workforce infrastructure for people with disabilities at the JW Marriott Houston, 5150 Westheimer, Houston, TX, from 9:15 a.m. until 10:15 a.m. on Wednesday, January 20, 2010.
El Camino Hospital, the hospital of Silicon Valley, expands its minimally invasive surgical program to three da Vinci® Si HD Surgical Systems. Physicians performed more than 500 robotic surgeries over the past year and expect the number to increase in 2010 as more physicians undergo training with the enhanced equipment that allows for more minimally invasive procedures.
Cancer causing high-risk human papillomaviruses (HR-HPV) are responsible for the rising incidence of HR-HPV–driven head and neck cancers (HNC), particularly oropharyngeal cancers (OPC, or throat cancers). Investigators have determined that HR-HPV DNA can be detected in saliva in most patients with HPV-driven OPC at the time of diagnosis. This work highlights a potentially life-saving screening program based on salivary HR-HPV DNA testing for early cancer detection and patient monitoring. Their findings appear in The Journal of Molecular Diagnostics, published by Elsevier.
Researchers in the United States have demonstrated the antiviral effect of three candidate nasal spray formulations against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COVID-19).
Phadia Inc., worldwide leaders in the development, manufacturing and marketing of complete blood test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases, today announced the launch of a two new, highly -reliable assays to support the accurate diagnosis of celiac disease.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225559826 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QF0400X | Clinic/center - Federally Qualified Health Center (fqhc) | 0874 (* (Not Available)) | Primary |
News Archive
The National Council on Disability (NCD) will release a report on workforce infrastructure for people with disabilities at the JW Marriott Houston, 5150 Westheimer, Houston, TX, from 9:15 a.m. until 10:15 a.m. on Wednesday, January 20, 2010.
El Camino Hospital, the hospital of Silicon Valley, expands its minimally invasive surgical program to three da Vinci® Si HD Surgical Systems. Physicians performed more than 500 robotic surgeries over the past year and expect the number to increase in 2010 as more physicians undergo training with the enhanced equipment that allows for more minimally invasive procedures.
Cancer causing high-risk human papillomaviruses (HR-HPV) are responsible for the rising incidence of HR-HPV–driven head and neck cancers (HNC), particularly oropharyngeal cancers (OPC, or throat cancers). Investigators have determined that HR-HPV DNA can be detected in saliva in most patients with HPV-driven OPC at the time of diagnosis. This work highlights a potentially life-saving screening program based on salivary HR-HPV DNA testing for early cancer detection and patient monitoring. Their findings appear in The Journal of Molecular Diagnostics, published by Elsevier.
Researchers in the United States have demonstrated the antiviral effect of three candidate nasal spray formulations against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COVID-19).
Phadia Inc., worldwide leaders in the development, manufacturing and marketing of complete blood test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases, today announced the launch of a two new, highly -reliable assays to support the accurate diagnosis of celiac disease.
› Verified 4 days ago
M. Hasan Yekta, M.d. P.c. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 27 Burnside Ave, East Hartford, CT 06108 Phone: 860-528-7161 | |
Family Medicine Center At East Hartford Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 775 Main St, East Hartford, CT 06108 Phone: 860-528-2138 Fax: 860-528-0514 | |
Silver Lane Medical Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 677 Silver Ln, East Hartford, CT 06118 Phone: 860-568-7243 Fax: 860-895-8107 | |
Dilligence Training Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 275 Park Ave, East Hartford, CT 06108 Phone: 860-292-0068 | |
First Choice Health Centers, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 478 Burnside Ave, East Hartford, CT 06108 Phone: 860-610-6183 | |
Pediatric & Adolescent Medicine Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 580 Burnside Ave, Suite 3, East Hartford, CT 06108 Phone: 860-282-7128 Fax: 860-646-1261 |